한국어
English
日本語
中文(简体)
Epclusa Tablets
100mg
Tablet · Prescription medication · Combination
Gilead Sciences Korea, Co., Ltd.
Velpatasvir is an antiviral component that inhibits the replication of the hepatitis C virus.
MFDS ingredient code M281345
Velpatasvir is an antiviral agent used in the treatment of hepatitis C, targeting the non-structural protein of the virus (NS5A). This component plays a role in disrupting the replication and assembly processes of the virus, preventing the spread of infection.
Velpatasvir binds to the NS5A protein within the hepatitis C virus, blocking the process by which the virus replicates its genetic material and produces new viral particles. As a result, the viral load decreases, and the infection is inhibited.
Approved uses differ by product. Check each product's information for its actual use.
Velpatasvir belongs to the NS5A inhibitor class and is used in combination with other antiviral agents to reduce the development of resistance and enhance therapeutic efficacy. Notably, it is effective against various genotypes of the hepatitis C virus.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
